Cytokinetics | CYTK - Current Assets



Cytokinetics reported $886.54M in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Acadia Pharmaceuticals USD 960.55M 89.61M Jun/2025
Amgen USD 26.73B 195M Jun/2025
Bayer EUR 33.75B 1.08B Jun/2025
Biogen USD 7.97B 341.7M Jun/2025
Bristol-Myers Squibb USD 33.22B 2.44B Jun/2025
Cytokinetics USD 886.54M 69.51M Jun/2025
Eisai JPY 763.15B 35.49B Jun/2025
Eli Lilly USD 49.85B 8.59B Jun/2025
Exelixis USD 1.18B 215.74M Jul/2025
Geron USD 505.6M 9.83M Jun/2025
Halozyme Therapeutics USD 1.12B 139.35M Jun/2025
Ionis Pharmaceuticals USD 2.58B 158.22M Jun/2025
Ligand Pharmaceuticals USD 352.94M 43.63M Jun/2025
Merck USD 37.07B 1.56B Jun/2025
Novartis USD 25.94B 831M Jun/2025
Pfizer USD 43.7B 2.16B Jun/2025
Regeneron Pharmaceuticals USD 16.86B 712.2M Jun/2025
Roche Holding CHF 40.04B 6.41B Dec/2024
Sanofi 37.02B 7B Jun/2025